This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the US, over 45% of the population has either diabetes or pre-diabetes 1. The absolute majority of those with diabetes have type 2 diabetes, which is usually associated with excess visceral fat and poor cardiometabolic health. Because a diagnosis of diabetes is very likely to shorten your life. Pre-Diabetes.
Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included.
No Diabetes or Pre-Diabetes. 2019 Aug 18;9(8):e029966. The Life Essential 8 are a set of factors that significantly influence your risk of heart disease and early death, including: Regular Physical Activity. Not smoking. Adequate Sleep. Normal Cholesterol Levels. Normal Blood Pressure. Endocr Pract. 2024 Nov;30(11):1089-1096.
ConclusionsSGLT2 inhibitors in patients with diabetes were independently associated with reduction in atherothrombotic major adverse cardiovascular events, allcause mortality, cardiovascular mortality, myocardial infarction, stroke, and incident dialysis, compared with DPP4 inhibitors.
We used conditional logistical regression models to estimate odds ratios and 95% CIs.RESULTS:There were 237 667 index admissions with AIS and diabetes during the study period. These results, if confirmed in other studies, emphasize the importance of avoiding hypoglycemic events in patients with diabetes.
UCSF researchers analyzed medical records from 29M adults who received hospital-based care in California from 2005 to 2019 (51yr avg. AFib rates increased dramatically during the study period, from 4.49% in 2005-2009 to 6.82% in 2015-2019. When these results are applied across the U.S., adult population.
Aims The aim of this study was to investigate a real-world heart failure (HF) cohort regarding (1) prevalence of known diabetes mellitus (DM), undiagnosed DM and pre-diabetes, (2) if hf treatment differs depending on glycaemic status and (3) if treatment of DM differs depending on HF phenotype.
Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes. Hypertension and diabetes were independent risk factors for pre-eclampsia. It is not known whether heart failure increases the risk of pre-eclampsia.
Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. from 2016‐2019 and secondary diagnosis of T2DM. from 2016‐2019 and secondary diagnosis of T2DM. Of those patients, 35.43% (n=273,993) were diabetic and 64.57% (n=151,112) were non‐diabetic.
Comorbidities like diabetes, hyperlipidemia, obesity, and hypothyroidism were less common in CUD patients, but substance abuse and mental health disorders were more prevalent. From 2016 to 2019, CUD among stroke survivors rose from 0.24% to 0.37%. vs. 45.1%), with a larger representation of black individuals (30.8% vs. 28.4%).
A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. percent of the patients treated between 2005 and 2009 to 6.82% of the patients treated between 2015 and 2019. million U.S.
BACKGROUND:Despite increasing incidences of hypertension, recent trends in mortality and urgent dialysis following acute hypertension (AHT) remain undetermined.METHODS:This retrospective observational cohort study evaluated 50 316 hospitalized AHT patients from 2010 to 2019, using an administrative claims database in Japan. were women.
Background:The current AHA stroke prevention guidelines give Class 1 recommendations that patients with AIS and diabetes should receive glucose-lowering agents with cardiovascular benefit to reduce risk of MACE. Patients were identified to have diabetes as derived by the Charlson Comorbidity Index ICD 10 codes E10 through E14.
Introduction:The paucity of large-scale data exploring the effect of prior bariatric surgery on recurrent stroke outcomes in elderly obese stroke survivors led us to address the gap, with an emphasis on the risk of recurrent stroke and its trends.Methods:A retrospective study was conducted using National Inpatient Sample data from 2016-2019.
In this study, we aim to analyze the MHO trends and outcomes with respect to Stroke.Methods:We queried the National Inpatient Sample (2016-2019) to identify Stroke hospitalizations in the elderly population (%E2%89%A565 years) with vs without MHO by using ICD-10 codes after excluding patients with Hypertension, analyze, and Diabetes Mellitus.
BackgroundPostpancreatectomy diabetes can be caused by resection of functioning pancreatic tissue and is associated with postoperative pancreatic islet cell mass loss and subsequent endocrine dysfunction. Diabetes is a well‐known risk factor for ischemic heart disease. Journal of the American Heart Association, Ahead of Print.
Diabetes (16.3% We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% in 2020 to 61.0% to 26.8%) and obesity (43.1%
mmol/l (197 mg/dl) with normal blood pressure who is a little overweight, does not smoke or have diabetes and has a family history of heart disease. Let’s see how it plays out with the impact of getting type 2 diabetes later rather than earlier in life. 2019 Apr;39(4):826-833. Lancet Diabetes Endocrinol.
However, there is ongoing debate whether intensive BP lowering may paradoxically increase the risk of cardiovascular disease (CVD), especially in patients with type 2 diabetes (T2D).
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] I think we live in a very exciting time right now for those who work in diabetes and cardiovascular disease.
Diabetes Care, Mardil Medical, and Catheter Robotics. Englund brings over 25 years of experience in the medical device industry, most recently serving as Senior Vice President, Scientific Affairs at Monteris Medical, where she established a strong clinical portfolio that was pivotal in achieving reimbursement and clinical guideline status.
Heart Disease in 2050 – The AHA warned of massive heart disease increases by 2050, spanning CVD (+60%), diabetes (+100%), obesity (+70%), hypertension (+44%), heart failure (+66%), and stroke (+100%). It’s well known that heart disease is the U.S.’s trillion, representing 4.6% of US GDP. If applied across the U.S., adult population.
If inflammation is successfully controlled, diseases – such as arthritis, pulmonary hypertension, Crohn's disease, inflammatory bowel diseases, diabetes, cancer and autoimmune diseases – can be treated more effectively. For years, Dr. Zanos has investigated bioelectronic medicine therapies to treat PAH.
The analysis also found smoking, Type 2 diabetes status, kidney damage, previous heart attack and high blood pressure are major modifiable determinants of developing heart failure over five to 10 years among American Indian adults. tim.hodson Wed, 08/21/2024 - 11:32 Aug.
Methods We prospectively included 1384 patients with LRHSs between March 2019 and March 2021. Therefore, this study aims to investigate the value of NISI in risk stratification and predicting cardiac events in patients with low-risk HEART scores (LRHSs).
Written by Magnus Nossen The patient in today's case is a male in his 70s with hypertension and type II diabetes mellitus. Figure-1: Reasons for the varied ECG presentation of acute LMain occlusion — excerpted from Dr. Smith’s 8/9/2019 post ( This Table from My Comment in the January 16, 2020 post ).
Intensive Blood Pressure Control: A Superior Approach Researchers investigated whether lowering systolic blood pressure to below 120 mm Hg offers greater benefits compared to a target of 140 mm Hg, especially for patients with diabetes or previous stroke. The benefits were consistent regardless of diabetes status or history of stroke.
A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. percent of the patients treated between 2005 and 2009 to 6.82% of the patients treated between 2015 and 2019. million U.S.
link] A 62 year old man with a history of hypertension, type 2 diabetes mellitus, and carotid artery stenosis called 911 at 9:30 in the morning with complaint of chest pain. From My Comment in the November 14, 2019 post in Dr. Smith's ECG Blog: A subject well worth periodic review — is the concept of Terminal QRS Distortion ( T-QRS-D ).
1.09]) in 2021 compared with 2019. 0.96]) decreased for low-income adults, while diabetes screening (RR 1.01 [0.95-1.08]) 0.96]) decreased for low-income adults, while diabetes screening (RR 1.01 [0.95-1.08]) 1.08]) increased and diabetes focused visits and insulin use remained stable. However, routine visits (RR 0.96 [0.94-0.98])
Reliability of self-reported risk factors was high in overweight (F1 0.81) and diabetes (F1 0.71), moderate in hearing impairment (F1 0.59) and hypertension (F1 0.56) and low in hypercholesterolemia (F1 0.49) and kidney disease (F1 0.25).
x) from 2016‐2019. The rate of 30‐day readmission was overall stable (7.34% in 2016 and 7.70% in 2019; p=0.42), but the 90‐day readmission rate slightly increased from 11.69% in 2016 to 12.47% in 2019 (p=0.04). ConclusionThe annual rate of 90‐day readmission, but not 30‐day readmission, increased from 2016 to 2019.
We aimed to examine the incidence of and risk factors for cardiotoxicity in a racially and ethnically diverse cohort with cancer treated with anthracyclines.MethodsWe included consecutive adult patients who underwent anthracyclinebased chemotherapy from 2016 to 2019 for any type of cancer. ResultsA total of 743 individuals were included (28.0%
GLP-1s Are So Hot Right Now – In the year since ACC 2023, GLP-1s went from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming a promising (and Medicare-covered) option for CV event reduction.
The multivariate model (area under curve = 0.93) had three significant predictors: diabetes mellitus (aOR 36.5, For inclusion, patients must have been successfully recanalized by mechanical thrombectomy with or without intravenous thrombolytic and ultimate modified thrombolysis in cerebral infarction (mTICI) score 2B/2C/3.
0.86, p<0.001) showed that patients had a higher likelihood of excellent recanalization with lower admission NIHSS (aOR 0.93, p = 0.036), no history of diabetes mellitus (DM) (aOR 0.42, p = 0.050), no prior stroke (aOR 0.27, p = 0.007), cerebral blood volume (CBV) index >= 0.7 (aOR excellent) revascularization.
x) from 2016‐2019 using the Nationwide Readmission Database (NRD). Data was weighted to allow for representative nationwide estimates.ResultsA total of 260,854 patients were admitted with a primary diagnosis of ICH between 2016‐2019. The mean age of the cohort was 68.49 years, with 52.6% being male.
This is a focused update to the 2019 NLA Scientific Statement on the Use of Lipoprotein(a) in Clinical Practice. Untangling the Statins and Diabetes Link : Dr. Savitha Subtamaniam explored the incidence of diabetes associated with statin use, noting that the mechanism is unclear. Targeting apoB to Lower ASCVD Risk : Dr.
Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular risk factors: heart failure, diabetes, atrial fibrillation, dyslipidemia and hypertension.
million (2019) and projected to reach 4.90 Stroke, Volume 55, Issue Suppl_1 , Page A52-A52, February 1, 2024. Background/Purpose:Stroke imposes a substantial healthcare burden, with ischemic stroke (IS) mortality rising from 2.04 million (1990) to 3.29 million by 2030 according to the Global Burden of Disease Study.
We aimed to investigate prevalence of prediabetes among people according to sleep apnea status.Methods:This cross-sectional study included 10131 Korean adults without diabetes with information of STOP-Bang score were identified from the dataset of the Korea National Health and Nutrition Examination Survey 2019-2021.
1,12,13 While it is important to treat all known risk factors that contribute to ASCVD including high blood pressure, hyperlipidemia, diabetes, and obesity, physicians also need to recognize and treat systemic inflammation in CV disease. 2019 Sep 10;140(11):e649-e650] [published correction appears in Circulation. Published 2019 Feb 28.
We evaluated the association between pretreatment clinical, imaging, and interventional parameters in patients who achieved mTICI 2c/3 versus 2b using multivariate logistic regressions.RESULTSFrom May 11, 2019 to October 9, 2022, 149 consecutive patients met our inclusion criteria (median 70 years old [interquartile range 65–78.5], 57.7%
This study evaluates the outcomes in patients admitted for HF with and without hyperkalemia.Methods:We used the Nationwide Readmissions Database (NRD) from 2016-2019, extracting adult patients with a primary diagnosis of HF who were admitted between January and November of each year. Survey procedures were applied using SAS 9.4.Results:We
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content